Mark Latina, MD
Enriched profileOphthalmologist, Glaucoma and Comprehensive Ophthalmology · Specialty Eye Consultants
Mark Latina is Ophthalmologist, Glaucoma and Comprehensive Ophthalmology at Specialty Eye Consultants. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 18 Oct 2026
Mark A. Latina, MD, is Ophthalmologist, Glaucoma and Comprehensive Ophthalmology at Specialty Eye Consultants, LLC (practice brand: Advanced Glaucoma Specialists), Reading, MA -- MGB Affiliated Provider. The public record shows 93 publications with 3,216 citations (h-index 26), centered on Glaucoma. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 30 companies, 1 NIH-funded awards (1987–1991).
- Top research focus: Glaucoma
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 30 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Clarifying the Optimal Application of SLT Therapy Trial
Sponsor: University of Pittsburgh
Industry payments
Updated 18 Oct 2026
30 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alcon Vision LLCProgram year202558 payments$35,736openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202568 payments$27,912openpaymentsdata.cms.gov ↗
- Sight Sciences, Inc.Program year202517 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
77.2%Prostaglandin Analog25.5%Bimatoprost61%Latanoprost23%Lumigan11%Tafluprost3%Travoprost2%Iyuzeh1%Part D + Part B<11 patientsCarbonic Anhydrase Inhibitor20.8%Dorzolamide-Timolol43%Brinzolamide21%Dorzolamide Hcl16%Acetazolamide7%Simbrinza4%Acetazolamide Er4%Azopt4%Cosopt Pf2%Part D<11 patients+ 9 more classes in this area
Cardiovascular
11.8%Beta blocker11.8%Timolol Maleate90%Betaxolol Hcl7%Betoptic S4%Part D<11 patientsNervous system
4.5%Cholinergic Receptor Agonist4.5%Pilocarpine Hcl100%Part D≥91 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
1 NIH research award on record, funded 1987–1991 per NIH RePORTER. The latest:
- PHOTOCHEMICAL TARGETING OF TRABECULAR MESHWORK CELLS
Schepens Eye Research Institute
FY1991K11EY000292 - PHOTOCHEMICAL TARGETING OF TRABECULAR MESHWORK CELLS
Schepens Eye Research Institute
FY1990K11EY000292 - PHOTOCHEMICAL TARGETING OF TRABECULAR MESHWORK CELLS
Schepens Eye Research Institute
FY1989K11EY000292
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/mark-latina-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/marklatina
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Mark-Latina
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
aao.org/education/interview/selective-laser-trabeculoplasty
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aao.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.massgeneralbrigham.org ↗
- BA Chemistry
Tufts University (Summa Cum Laude, Phi Beta Kappa)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →specialtyeyeconsultants.com ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Academy of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →specialtyeyeconsultants.com ↗
Secondary affiliations
appointments beyond the home institution- Associate Clinical Professor of Ophthalmology
Tufts University School of Medicine / New England Medical Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →specialtyeyeconsultants.com ↗ - Staff appointment
Massachusetts Eye and Ear Infirmary, Harvard Medical School
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →specialtyeyeconsultants.com ↗ - Staff appointment
Massachusetts General Hospital, Harvard Medical School (Wellman Laboratory of Photomedicine, research staff)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →specialtyeyeconsultants.com ↗
Media & interviews
press, podcasts and appearances- Featured expert video
"Mark Latina, M.D. Discusses Glaucoma Tube Shunt Technology", AAO 2012, OphthalmologyWeb
2012verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ophthalmologyweb.com ↗ - Podcast guest
"Dr. Mark Latina and Dr. Gus Gazzard: SLT, LiGHT Trial, Glaucoma", The History of Eyecare podcast, episode 16
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thehistoryofeyecare.com ↗ - Educational contributor
"Why Your Glaucoma Suspects Deserve Another Look: ERG and SLT", Diopsys resource
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diopsys.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →eyetube.net ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital